Antipsychotic Agents: all 1,683 studies that test it

Page 4 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.

• Sequential Multiple Assignment Treatment for Bipolar DisorderCompletedNCT01588457Phase 4Results posted
• An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress DisorderCompletedNCT01587118Phase 4Results posted
• Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)CompletedNCT01577186Phase 4Results posted
• A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With SchizophreniaCompletedNCT01577160Phase 4Results posted
• This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296CompletedNCT01575561Phase 3Results posted
• High Dose Lurasidone for Patients With Treatment Resistant SchizophreniaCompletedNCT01569659Phase 4Results posted
• A Twelve Week, Open Label Extension Study in Patients With SchizophreniaCompletedNCT01566162Phase 3Results posted
• A Long-Term Study of JNS007ER in Patients With SchizophreniaCompletedNCT01561898Phase 3Results posted
• Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than AripiprazoleCompletedNCT01552772Phase 1Results posted
• Once-Daily Asenapine for SchizophreniaCompletedNCT01549041Phase 4Results posted
• A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With SchizophreniaCompletedNCT01541371Phase 3Results posted
• A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With SchizophreniaCompletedNCT01529515Phase 3Results posted
• Gao Bipolar Spectrum Lithium/Quetiapine StudyTerminatedNCT01526148Phase 4Results posted
• An Open-label Safety Study of Pimavanserin in Parkinson's Disease PatientsCompletedNCT01518309Phase 2Results posted
• Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With SchizophreniaCompletedNCT01515423Phase 3Results posted
• Phase II Dose-ranging Study of APD421 in PONVCompletedNCT01510704Phase 2Results posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleTerminatedNCT01509053Phase 3Results posted
• Metabolic Effects of Olanzapine in Healthy MalesCompletedNCT01496183Not applicableResults posted
• RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT01490086Phase 2Results posted
• Lurasidone Extended Use StudyCompletedNCT01485640Phase 3Results posted
• Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive DisorderCompletedNCT01469377Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With SchizophreniaCompletedNCT01469039Phase 3Results posted
• Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and IrritabilityCompletedNCT01464229Phase 4Results posted
• Asenapine in the Treatment of Older Adults With Bipolar DisorderCompletedNCT01460290Phase 4Results posted
• Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's TypeCompletedNCT01438060Phase 3Results posted
• PEARL Schizophrenia MaintenanceCompletedNCT01435928Phase 3Results posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleCompletedNCT01432444Phase 3Results posted
• Sustaining Remission of Psychotic DepressionCompletedNCT01427608Phase 4Results posted
• Major Depressive Disorder With Mixed Features - ExtensionCompletedNCT01423253Phase 3Results posted
• VA Augmentation and Switching Treatments for Improving Depression OutcomesCompletedNCT01421342Phase 3Results posted
• Major Depressive Disorder (MDD) With Mixed Features - Flexible DoseCompletedNCT01421134Phase 3Results posted
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)CompletedNCT01418352Phase 3Results posted
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01418339Phase 3Results posted
• Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01416441Phase 3Results posted
• A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With SchizophreniaCompletedNCT01412060Phase 3Results posted
• Risperidone and Desipramine in Alcohol Use and SchizophreniaCompletedNCT01411085Phase 2Results posted
• Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary HeadachesTerminatedNCT01406860Not applicableResults posted
• Treating Acutely Agitated Patients With Asenapine Sublingual TabletsCompletedNCT01400113Phase 4Results posted
• Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar DepressionCompletedNCT01396447Phase 2Results posted
• Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia ParticipantsCompletedNCT01387542Phase 4Results posted
• Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 YearsCompletedNCT01362439Phase 4Results posted
• Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or DivalproexCompletedNCT01358357Phase 3Results posted
• Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)CompletedNCT01349907Phase 3Results posted
• Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With SchizophreniaCompletedNCT01338298Not applicableResults posted
• Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)CompletedNCT01333072Phase 4Results posted
• Comparative Effectiveness Study for Bipolar DisorderCompletedNCT01331304Phase 4Results posted
• An Efficacy and Safety Study of Paliperidone Palmitate in Participants With SchizophreniaCompletedNCT01299389Phase 3Results posted
• Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)CompletedNCT01293825Phase 4Results posted
• Aripiprazole Effects on Alcohol Drinking and CravingCompletedNCT01292057Phase 3Results posted
• Relapse Prevention Study in Patients With SchizophreniaCompletedNCT01291511Phase 3Results posted
• Different Safety Profile of Risperidone and Paliperidone Extended-releaseCompletedNCT01284959Phase 4Results posted
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I DepressionCompletedNCT01284517Phase 3Results posted
• Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar DepressionCompletedNCT01256177Phase 3Results posted
• The Effects of Dopamine on Reward ProcessingCompletedNCT01253421Phase 1Results posted
• Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)CompletedNCT01244828Phase 3Results posted
• Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)CompletedNCT01244815Phase 3Results posted
• Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for BenzodiazepinesTerminatedNCT01244711Phase 4Results posted
• Ecopipam Treatment of Tourette SyndromeCompletedNCT01244633Phase 1/2Results posted
• Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic DisorderCompletedNCT01227668Phase 4Results posted
• Clinical Study to Determine if Ecopipam Can Reduce Urges to GambleCompletedNCT01215357Phase 2Results posted
• The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) StudyCompletedNCT01211522Phase 3Results posted
• Switching to Iloperidone From Other Antipsychotics in SchizophreniaCompletedNCT01207414Phase 4Results posted
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)CompletedNCT01206517Phase 1Results posted
• Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy VolunteersCompletedNCT01204255Not applicableResults posted
• Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar DisorderCompletedNCT01195363Phase 4Results posted
• A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderCompletedNCT01193153Phase 3Results posted
• Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)CompletedNCT01190267Phase 3Results posted
• Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)CompletedNCT01190254Phase 3Results posted
• Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy SubjectsCompletedNCT01188668Phase 4Results posted
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisCompletedNCT01174004Phase 3Results posted
• Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)CompletedNCT01172652Phase 4Results posted
• Olanzapine Versus Placebo for Outpatients With Anorexia NervosaCompletedNCT01170117Not applicableResults posted
• Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive DisorderCompletedNCT01168674Phase 4Results posted
• 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedCompletedNCT01157351Phase 4Results posted
• Customized Adherence Enhancement Plus Long-acting Injectable AntipsychoticCompletedNCT01152697Not applicableResults posted
• Efficacy & Safety Study of Oral Aripiprazole in Adolescents With SchizophreniaCompletedNCT01149655Phase 3Results posted
• A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective DisorderCompletedNCT01143090Phase 3Results posted
• A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic AgentsCompletedNCT01143077Phase 3Results posted
• Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)CompletedNCT01142596Phase 3Results posted
• A Comparison of Long-acting Injectable Medications for SchizophreniaCompletedNCT01136772Phase 4Results posted
• Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic RegulationCompletedNCT01134731Phase 4Results posted
• ACP for Local Application in Ankle ArthrodesisTerminatedNCT01131455Not applicableResults posted
• An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaCompletedNCT01129882Phase 3Results posted
• Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current TherapyTerminatedNCT01128114Phase 4Results posted
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01123707Phase 3Results posted
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.TerminatedNCT01122927Phase 3Results posted
• One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic SyndromeTerminatedNCT01113541Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111565Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111552Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111539Phase 3Results posted
• Long-term Study of Cariprazine in Patients With SchizophreniaCompletedNCT01104792Phase 3Results posted
• Safety and Efficacy of Cariprazine in SchizophreniaCompletedNCT01104779Phase 3Results posted
• Safety and Efficacy of Cariprazine in Patients With SchizophreniaCompletedNCT01104766Phase 3Results posted
• 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)CompletedNCT01098110Phase 3Results posted
• Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral AntipsychoticsCompletedNCT01081769Phase 3Results posted
• Post-Traumatic Stress Disorder (PTSD) and SeroquelCompletedNCT01066156Not applicableResults posted
• Generalized Anxiety and SeroquelTerminatedNCT01066143Not applicableResults posted
• Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan DiseaseCompletedNCT01065558Phase 1Results posted
• Long-term Safety and Tolerability of Cariprazine for Bipolar I DisorderCompletedNCT01059539Phase 3Results posted
• Safety and Efficacy of Cariprazine for Bipolar I DisorderCompletedNCT01058668Phase 3Results posted

← Antipsychotic Agents overview